Sweeping review suggests weight-loss drugs’ effect on 175 conditions
The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
Weight-loss drugs may boost health in many ways
The first study to assess how weight-loss drugs affect the whole of human health has discovered an "eye-opening" impact on ...
Popular weight-loss drugs linked to cognitive benefits but may pose kidney risks
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study ...
Largest-ever Ozempic and GLP-1 drug study finds they lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
Live Science on MSN5h
Ozempic-style drugs tied to more than 60 health benefits and risks in biggest study-of-its-kind
A large new study has shed light on the wider health impacts of taking Ozempic-style drugs. Weight-loss drugs like Ozempic ...
Nature22h
Obesity drugs: huge study highlights new health risks
Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.
Weight-loss jabs may have wider health benefits, study suggests
The use of weight-loss jabs may be associated with wider health benefits including lower risk of stroke and dementia, a study ...
Weight loss jabs DOUBLE risk of deadly condition, major study finds - patients in hospital due to the medication soar
The risks of 'miracle' weight loss jabs such as Ozempic, Wegovy and Mounjaro have been laid bare by a landmark study ...